62584-32-1 Usage
Uses
Used in Pharmaceutical Industry:
2-Chloro-3-(trifluoromethyl)benzonitrile is used as a chemical intermediate for the synthesis of pharmaceuticals. Its unique structure contributes to the development of new drugs, potentially enhancing their efficacy and selectivity in treating various medical conditions.
Used in Agrochemical Industry:
In the agrochemical sector, 2-Chloro-3-(trifluoromethyl)benzonitrile is utilized as an intermediate in the production of agrochemicals. It aids in the creation of compounds that can be used for pest control and crop protection, thereby supporting agricultural productivity.
Used in Organic Synthesis:
2-Chloro-3-(trifluoromethyl)benzonitrile also serves as a building block in organic synthesis, allowing for the construction of a wide range of organic compounds with diverse applications across various industries.
Safety Precautions:
Check Digit Verification of cas no
The CAS Registry Mumber 62584-32-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,2,5,8 and 4 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 62584-32:
(7*6)+(6*2)+(5*5)+(4*8)+(3*4)+(2*3)+(1*2)=131
131 % 10 = 1
So 62584-32-1 is a valid CAS Registry Number.
InChI:InChI=1/C8H3ClF3N/c9-7-5(4-13)2-1-3-6(7)8(10,11)12/h1-3H
62584-32-1Relevant academic research and scientific papers
Structure-activity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonists
Nelson, Derek W.,Gregg, Robert J.,Kort, Michael E.,Perez-Medrano, Arturo,Voight, Eric A.,Wang, Ying,Grayson, George,Namovic, Marian T.,Donnelly-Roberts, Diana L.,Niforatos, Wende,Honore, Prisca,Jarvis, Michael F.,Faltynek, Connie R.,Carroll, William A.
, p. 3659 - 3666 (2007/10/03)
1-Benzyl-5-aryltetrazoles were discovered to be novel antagonists for the P2X? receptor. Structure-activity relationship (SAR) studies were conducted around both the benzyl and phenyl moieties. In addition, the importance of the regiochemical substitution
THE USE OF SELECTIVE P2X7 RECEPTOR ANTAGONISTS
-
Page/Page column 69-70, (2008/06/13)
The present invention relates to the use of selective P2X7 receptor antagonists of formula (I), or a pharmaceutically acceptable salt or prodrug thereof wherein D, R1 and R2 are as defined in claim 1, for the treatment of neuropathic pain, chronic inflammatory pain, inflammation, neurodegeneration and for promoting neuroregeneration.
